Home/Filings/4/A/0001209191-24-003864
4/A//SEC Filing

Gathy Michael 4/A

Accession 0001209191-24-003864

CIK 0001311370other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 6:58 PM ET

Size

22.5 KB

Accession

0001209191-24-003864

Insider Transaction Report

Form 4/AAmended
Period: 2024-02-13
Gathy Michael
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-02-16$38.03/sh76$2,890118 total
  • Sale

    Common Stock

    2024-02-21$37.62/sh5$1880 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-136625,074 total
    From: 2024-02-13Exp: 2024-02-13Common Stock (662 underlying)
  • Sale

    Common Stock

    2024-02-15$37.90/sh155$5,875194 total
  • Sale

    Common Stock

    2024-02-20$38.28/sh99$3,79019 total
  • Exercise/Conversion

    Common Stock

    2024-02-13+662662 total
  • Sale

    Common Stock

    2024-02-21$37.29/sh14$5225 total
  • Tax Payment

    Common Stock

    2024-02-13$38.55/sh277$10,678385 total
  • Sale

    Common Stock

    2024-02-14$37.36/sh36$1,345349 total
Footnotes (13)
  • [F1]Shares of Common Stock were acquired by the Reporting Person upon the vesting of the relevant portion of prior grants of Restricted Stock Units ("RSUs").
  • [F10]The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on February 21, 2024 in trades with average execution prices ranging from $37.09 to $37.50, inclusive.
  • [F11]The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on February 21, 2024 in trades with average execution prices ranging from $37.51 to $38.16, inclusive.
  • [F12]Each RSU represents a contingent right to receive one share of Common Stock.
  • [F13]As previously announced by the issuer in a Current Report on Form 8-K filed on February 1, 2024, the issuer accelerated vesting of certain deferred incentive compensation awards, including the Reporting Person's RSUs reported herein, which were originally scheduled to vest March 1, 2024.
  • [F2]Represents shares of Common Stock withheld by the issuer to cover taxes arising from the vesting of RSUs referenced in Footnote (1).
  • [F3]Represents the New York Stock Exchange closing price of Common Stock on the trading day immediately preceding the vesting date of the RSUs referenced in Footnote (1).
  • [F4]In connection with the vesting of RSUs, the issuer permitted its employees to make an election during an open trading window while not in possession of material non-public information for an independent broker to sell shares of Common Stock in multiple transactions on the open market at prevailing market prices from February 14, 2024 through March 1, 2024. The Reporting Person irrevocably committed to sell an aggregate of 385 shares of Common Stock in accordance with the foregoing procedures. The independent broker completed the sales of all such shares of Common Stock on February 21, 2024.
  • [F5]This report is being filed to amend the Reporting Person's Form 4 filed on February 15, 2024, which Form 4 included an estimated transaction price.
  • [F6]The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
  • [F7]The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on February 15, 2024 in trades with average execution prices ranging from $37.31 to $38.05, inclusive.
  • [F8]The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on February 16, 2024 in trades with average execution prices ranging from $37.73 to $38.20, inclusive.
  • [F9]The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on February 20, 2024 in trades with average execution prices ranging from $37.81 to $38.63, inclusive.

Issuer

Lazard, Inc.

CIK 0001311370

Entity typeother

Related Parties

1
  • filerCIK 0001995399

Filing Metadata

Form type
4/A
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:58 PM ET
Size
22.5 KB